U.S. flag

An official website of the United States government

NM_005902.4(SMAD3):c.490A>T (p.Thr164Ser) AND Aneurysm-osteoarthritis syndrome

Germline classification:
Uncertain significance (1 submission)
Last evaluated:
Nov 20, 2023
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV004006439.2

Allele description [Variation Report for NM_005902.4(SMAD3):c.490A>T (p.Thr164Ser)]

NM_005902.4(SMAD3):c.490A>T (p.Thr164Ser)

Gene:
SMAD3:SMAD family member 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
15q22.33
Genomic location:
Preferred name:
NM_005902.4(SMAD3):c.490A>T (p.Thr164Ser)
HGVS:
  • NC_000015.10:g.67165342A>T
  • NG_011990.1:g.104486A>T
  • NM_001145102.2:c.175A>T
  • NM_001145103.2:c.358A>T
  • NM_005902.4:c.490A>TMANE SELECT
  • NP_001138574.1:p.Thr59Ser
  • NP_001138575.1:p.Thr120Ser
  • NP_005893.1:p.Thr164Ser
  • NC_000015.9:g.67457680A>T
  • NC_000015.9:g.67457680A>T
  • NM_005902.3:c.490A>T
Protein change:
T120S
Links:
dbSNP: rs1254152984
NCBI 1000 Genomes Browser:
rs1254152984
Molecular consequence:
  • NM_001145102.2:c.175A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001145103.2:c.358A>T - missense variant - [Sequence Ontology: SO:0001583]
  • NM_005902.4:c.490A>T - missense variant - [Sequence Ontology: SO:0001583]
Observations:
2

Condition(s)

Name:
Aneurysm-osteoarthritis syndrome
Synonyms:
ANEURYSMS-OSTEOARTHRITIS SYNDROME; LOEYS-DIETZ SYNDROME WITH OSTEOARTHRITIS; Loeys-Dietz syndrome 3; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0013426; MedGen: C3151087; Orphanet: 284984; OMIM: 613795

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV004815355All of Us Research Program, National Institutes of Health
criteria provided, single submitter

(ACMG Guidelines, 2015)
Uncertain Significance
(Nov 20, 2023)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknown2not providednot provided108544not providedclinical testing

Citations

PubMed

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.

Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL; ACMG Laboratory Quality Assurance Committee..

Genet Med. 2015 May;17(5):405-24. doi: 10.1038/gim.2015.30. Epub 2015 Mar 5.

PubMed [citation]
PMID:
25741868
PMCID:
PMC4544753

Details of each submission

From All of Us Research Program, National Institutes of Health, SCV004815355.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not provided2not providednot providedclinical testing PubMed (1)

Description

This missense variant replaces threonine with serine at codon 164 of the SMAD3 protein. Computational prediction is inconclusive regarding the impact of this variant on protein structure and function (internally defined REVEL score threshold 0.5 < inconclusive < 0.7, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with cardiovascular disorders in the literature. This variant has been identified in 1/251442 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknown108544not providednot provided2not providednot providednot provided

Last Updated: Sep 1, 2024